HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures

There is no fulltext present in this item.

Title:	HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
Author(s):	Davies, H.; Glodzik, D.; Morganella, S.; Yates, L.R.; Staaf, J.; Zou, X.; Ramakrishna, M.; Martin, S.; Boyault, S.; Sieuwerts, A.M.; Simpson, P.T.; King, T.A.; Raine, K.; Eyfjord, J.E.; Kong, G.; Borg, Å.; Birney, E.; Stunnenberg, H.G. ; Vijver, M.J. van de; Børresen-Dale, A.L.; Martens, J.W.M.; Span, P.N. ; Lakhani, S.R.; Vincent-Salomon, A.; Sotiriou, C.; Tutt, A.; Thompson, A.M.; Laere, S. van; Richardson, A.L.; Viari, A.; Campbell, P.J.; Stratton, M.R.; Nik-Zainal, S.
Publication year:	2017
Source:	Nature Medicine, vol. 23, iss. 4, (2017), pp. 517-525
ISSN:	1078-8956
DOI:	https://doi.org/10.1038/nm.4292
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/175041
Display more details
Subject:	Molecular Biology Radboudumc 17: Women's cancers RIMLS: Radboud Institute for Molecular Life Sciences Tijdelijke code tbv inlezen publicaties Radboudumc - Alleen voor gebruik door Radboudumc
Organization:	Molecular Biology Radiation Oncology Laboratory Medicine
Journal title:	Nature Medicine
Volume:	vol. 23
Issue:	iss. 4
Page start:	p. 517
Page end:	p. 525